Hedge Fund Alert Quotes Hedge Funds Leader Laurel FitzPatrick on TALF Fund
In a July 1 Hedge Fund Alert article on TALF funds, asset management partner Laurel FitzPatrick notes that Ropes & Gray’s private funds ...
In The Wall Street Journal Pro Private Equity Asset Management Partner Isabel Dische Discusses Secondary Transactions Amid the COVID-19 Pandemic
A July 5 article published by The Wall Street Journal Pro Private Equity titled “Fund Recapitalizations Grind to Halt as Pandemic Upends Valuations, ...
Ropes & Gray Represents GIC in MultiPlan Inc. Transaction
Ropes & Gray represented GIC, Singapore's sovereign wealth fund, in connection with MultiPlan Inc.’s proposed merger with Churchill Capital Corp. III ...
Asset Management Partner Jason Brown Discusses the SEC’s Risk Alert in The WSJ Pro Private Equity
A Risk Alert from the U.S. Securities and Exchange Commission details deficiencies found in recent examinations of private funds. Insights from asset management partner ...
In Law360, Health Care Attorneys Examine CMS Proposed Rule for Value-Based Purchasing Arrangements
The Centers for Medicare & Medicaid Services issued a proposed rule that, if finalized, would modify significantly the current Medicaid Drug Rebate Program regulations. The ...
In Law360, Emerging Technologies Attorney Marta Belcher Addresses Court Privacy Ruling on Cryptocurrency Warrantless Searches
In Law360, blockchain and emerging technologies attorney Marta Belcher (Silicon Valley) discussed a novel Fifth Circuit ruling that the government need not get a warrant ...
Ama Adams, Brendan Hanifin and Emerson Siegle Provide Mid-Year Look at Sanctions Developments
Litigation & enforcement partner Ama Adams, counsel Brendan Hanifin and associate Emerson Siegle co-authored an article published by Law360 that provides a midyear look ...
Ropes & Gray Advises Arsenal Capital Partners on £178 million Proposed Acquisition of Cello Health
Ropes & Gray has advised Arsenal Capital Partners – a US headquartered private equity firm with a strong track record in the life sciences market ...
Ropes & Gray Represents Goldfinch Bio in Securing $100 Million in Series B Financing
Ropes & Gray represented Goldfinch Bio in securing $100 million in Series B financing. The transaction was announced on June 30. The financing ...
Eva Carman, Alexander Simkin and Patrick Roath Examine Televisa and its Impact on Securities Litigation
Litigation & enforcement partner Eva Carman, counsel Alexander Simkin and associate Patrick Roath co-authored an article published by Law360 that examines how the decision ...
Chris Conniff Discusses Risks to Major League Baseball Reopening
In Law360, litigation & enforcement partner and head of the firm’s sports industry group, Chris Conniff (New York) discusses considerations Major League ...
In The Review of Securities & Commodities Regulation, Amy Roy, Jonathan Ference-Burke and Hannah Vail Analyze Recent Mutual Fund Fee Litigation
In the decade since the Supreme Court’s decision in Jones v. Harris Associates – a case in which Ropes & Gray represented the ...
María González Calvet discusses the Anti-Corruption Revolution in Latin America during 2020 ABA International Law Section Meeting
María González Calvet, co-chair of Ropes & Gray’s global anti-corruption and international risk practice and Latin America ...
Ropes & Gray Represents B Capital Group in Second Fundraising
Ropes & Gray represented B Capital Group in raising $820 million for its second fund. The Fund announced its final close on June 30. The ...
Ropes & Gray Represents Kohlberg & Co. in its Acquisition of GPRS Holdings LLC from CIVC Partners LP
Ropes & Gray represented Kohlberg & Co. in its acquisition of a majority stake in GPRS Holdings LLC from CIVC Partners LP. The company's ...
In Law360, Attorneys Analyze Expanded U.S. Government Scrutiny of Research Compliance
The U.S. Department of Justice, lawmakers and federal funding agencies are pushing forward with efforts to raise attention to researchers with undisclosed research and ...
Ropes & Gray Advises Bridgepoint on its Investment into Matrix
Ropes & Gray has advised Bridgepoint on its investment in Matrix SCM, a leading managed service provider for the outsourced hiring and management of ...
Ropes & Gray Represents uniQure in $1.6 Billion Global Licensing Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy
Ropes & Gray represented Amsterdam-based gene therapy company uniQure N.V. in a licensing agreement to provide biopharmaceutical company CSL Behring with exclusive global ...
Ropes & Gray Successfully Defends TCL and Roku in High-Profile Lawsuit Alleging Infringement of TCL Roku TVs
Ropes & Gray secured an extremely favorable settlement on behalf of Roku, Inc. and TCL Electronics Holdings Ltd. (and related entities) in a five-patent ...
Ropes & Gray Represents Charlesbank Capital Partners in its Investment in Aptean
Ropes & Gray represented funds affiliated with Charlesbank Capital Partners in its investment in Aptean, a global provider of mission-critical, industry-specific enterprise resource ...
Ropes & Gray Joins More than 125 Law Firms as Charter Member of New Law Firm Antiracism Alliance
Ropes & Gray is a charter member of the new Law Firm Antiracism Alliance, announced on June 24, and profiled in The American Lawyer. The ...
Ropes & Gray Represents Perella Weinberg Partners as Financial Advisor to Invitae in $1.4 Billion Combination with ArcherDX
Ropes & Gray represented Perella Weinberg Partners as financial advisor to Invitae in its announced combination with ArcherDX to create a global leader in comprehensive ...
Ropes & Gray Advises Sculptor Capital Management on Real Estate Fund IV
Sculptor Capital Management announced on June 23 the final close of its fourth opportunistic real estate fund, Sculptor Real Estate Fund IV LP (SRE IV ...
Ropes & Gray Represents Gilead Sciences in its Exclusive Option to Acquire Pionyr Immunotherapeutics consisting of the acquisition by Gilead of a 49.9% equity interest for $275 million, an Option for Gilead to Acquire the Remaining equity interests for $315 million, and up to $1.15 billion of Potential Future Milestone Payments to Pionyr equityholders
Ropes & Gray represented Gilead Sciences, Inc. in its exclusive option to acquire Pionyr Immunotherapeutics Inc., a privately held company developing cancer immunotherapies. The ...
In CNBC, Megan Bisk Explores Employer Liability from COVID-19 Workplace Lawsuits
As stores, restaurants and offices reopen in parts of the U.S. following coronavirus shutdowns, many businesses are worried about lawsuits from infected workers and ...